Published in Intest Res on April 29, 2014
Rice prolamin extract ameliorates acute murine colitis by inhibiting nuclear factor-kappa B and modulating intestinal apoptosis and cell proliferation. Clin Exp Immunol (2014) 0.79
Allium cepa L. and Quercetin Inhibit RANKL/Porphyromonas gingivalis LPS-Induced Osteoclastogenesis by Downregulating NF-κB Signaling Pathway. Evid Based Complement Alternat Med (2015) 0.75
Natural products as sources of new drugs over the period 1981-2002. J Nat Prod (2003) 8.03
Drug discovery from medicinal plants. Life Sci (2005) 4.26
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol (2006) 3.01
Natural products: an evolving role in future drug discovery. Eur J Med Chem (2011) 2.07
Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol (1999) 2.06
Key factors in the rising cost of new drug discovery and development. Nat Rev Drug Discov (2004) 1.88
Tormentil for active ulcerative colitis: an open-label, dose-escalating study. J Clin Gastroenterol (2007) 1.50
Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci (2005) 1.46
Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther (2006) 1.44
A synthesis strategy yielding skeletally diverse small molecules combinatorially. J Am Chem Soc (2004) 1.40
The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol (2001) 1.27
Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med (2001) 1.27
Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol (2002) 1.21
The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact (2000) 1.20
In the arms of Morpheus the development of morphine for postoperative pain relief. Can J Anaesth (2000) 1.19
Plant-derived natural product research aimed at new drug discovery. J Nat Med (2008) 1.15
Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci (2006) 1.11
Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol (2004) 1.10
Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther (2004) 1.10
Trends in development and approval times for new therapeutics in the United States. Nat Rev Drug Discov (2003) 1.10
Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis (2002) 1.08
Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 1.08
Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. Eur J Pharmacol (2007) 1.04
Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis. World J Gastroenterol (2006) 1.01
Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules (2013) 0.99
Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int J Colorectal Dis (2001) 0.98
Attenuation of colitis injury in rats using Garcinia cambogia extract. Phytother Res (2009) 0.97
Crocin and geniposide profiles and radical scavenging activity of gardenia fruits (Gardenia jasminoides Ellis) from different cultivars and at the various stages of maturation. Fitoterapia (2009) 0.94
Polyphenols and gastrointestinal diseases. Curr Opin Gastroenterol (2006) 0.92
Review of natural products actions on cytokines in inflammatory bowel disease. Nutr Res (2012) 0.91
Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice. J Ethnopharmacol (2012) 0.90
Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine (2008) 0.90
Ginger extract and zingerone ameliorated trinitrobenzene sulphonic acid-induced colitis in mice via modulation of nuclear factor-κB activity and interleukin-1β signalling pathway. Food Chem (2012) 0.89
Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther (2002) 0.89
Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication. Digestion (2012) 0.88
The possible mechanisms of Fructus Mume pill in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats. J Ethnopharmacol (2009) 0.87
Plant originated glycoprotein has anti-oxidative and anti-inflammatory effects on dextran sulfate sodium-induced colitis in mouse. J Biomed Sci (2006) 0.87
Drug discovery and development with plant-derived compounds. Prog Drug Res (2008) 0.87
Immunotoxicology: role in the safety assessment of drugs. Drug Saf (2005) 0.87
Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother (2008) 0.86
New concepts, experimental approaches, and dereplication strategies for the discovery of novel phytoestrogens from natural sources. Planta Med (2013) 0.84
Coriolus versicolor suppresses inflammatory bowel disease by Inhibiting the expression of STAT1 and STAT6 associated with IFN-γ and IL-4 expression. Phytother Res (2011) 0.84
Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci (1998) 0.84
Effect of oral administration of tormentil root extract (Potentilla tormentilla) on rotavirus diarrhea in children: a randomized, double blind, controlled trial. Pediatr Infect Dis J (2003) 0.83
Topical application of glycyrrhizin preparation ameliorates experimentally induced colitis in rats. World J Gastroenterol (2011) 0.82
Boswellic acid, a potent antiinflammatory drug, inhibits rejection to the same extent as high dose steroids. Transplant Proc (2001) 0.82
Rutoside as mucosal protective in acetic acid-induced rat colitis. Planta Med (1997) 0.81
Current prodrug design for drug discovery. Curr Pharm Des (2009) 0.80
[News of the discovery of acids in organic material by C.W. Scheele (author's transl)]. Pharmazie (1981) 0.76
Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J Clin Gastroenterol (2003) 2.03
Expression of cyclooxygenase-2 protein in colorectal carcinomas. Int J Gastrointest Cancer (2002) 1.06
Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Digestion (2002) 1.02
Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver (2013) 0.83
Increased Expression of Brain-derived Neurotrophic Factor in Irritable Bowel Syndrome and Its Correlation With Abdominal Pain (Gut 2012;61:685-694). J Neurogastroenterol Motil (2013) 0.82
Parathyroid cyst presenting as acute pancreatitis: report of a case. Chonnam Med J (2013) 0.78
Association between interleukin-18 gene polymorphism and Helicobacter pylori infection in the Korean population. Sci Rep (2015) 0.75
Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers. Oncotarget (2016) 0.75
Gastric and splenic infarctions in acute pancreatitis. J Dig Dis (2016) 0.75
Risk of advanced colorectal neoplasm in patients with more than 10 adenomas on index colonoscopy: A Korean Association for the Study of Intestinal Diseases (KASID) Study. J Gastroenterol Hepatol (2016) 0.75